Rights and permissions
About this article
Cite this article
New trimetazidine formulation benefits clinical, QOL status. Pharmacoecon. Outcomes News 469, 13 (2005). https://doi.org/10.2165/00151234-200504690-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504690-00023